Indira IVF, a renowned fertility clinic chain based in Udaipur, is set to embark on an expansive journey into maternal and child healthcare, unveiling plans to establish up to 25 hospitals across India. Dr. Kshitiz Murdia, CEO of Indira IVF Group, shared insights in an exclusive interview with Moneycontrol, outlining the strategic vision that includes affordable services catering to a broader socio-economic segment.
Expanding Horizons:
Dr. Murdia disclosed that the first phase of expansion would witness the launch of 10 mother and childcare hospitals over the next two years. These hospitals are slated to begin operations in key locations such as Dehradun, Varanasi, and Pune, marking the initial steps in a broader plan to operate 25-30 hospitals across the country within the next five years. This ambitious venture is part of Indira IVF’s broader strategy to diversify its healthcare offerings and compete with established players like Rainbow Hospitals, Cloudnine, Apollo Cradle, and Fortis La Femme.
Affordability as a Key Pillar:
In a deliberate departure from the current trend of catering to the elite, Dr. Murdia emphasized the need to bridge the gap in maternal and child care services for the socio-economic class B and C populations. He highlighted the focus on affordability, a crucial aspect often overlooked in the industry. Indira IVF aims to bring these high-margin services within reach of a larger section of the population, ensuring accessibility without compromising on quality.
Seamless Care Through Pregnancy:
Dr. Murdia underscored the complexities and risks associated with IVF pregnancies, necessitating comprehensive care. The forward integration into mother and childcare services ensures a seamless continuum of care, including Neonatal Intensive Care Units (NICU), addressing potential complications and risks associated with IVF pregnancies. This holistic approach aims to redefine the standards of care throughout the pregnancy and neonatal phases.
International Ventures and Strategic Expansion:
To navigate the competitive landscape, Indira IVF strategically eyes expansion in regions with limited presence, specifically targeting Tamil Nadu and Kerala. The company is also poised to venture into international markets, with operations set to commence in Nepal and Bangladesh in early 2024. This global foray aligns with the company’s commitment to bringing its expertise to new geographies.
Financial Snapshot:
In FY 23, Indira IVF reported robust financials, with revenues reaching Rs 1,218 crore and a net profit of Rs 180 crore. The fertility clinic, which originated as a standalone clinic in Udaipur in 1988, has evolved into a key player in infertility treatments, boasting over 120 centers nationwide.
As Indira IVF diversifies its healthcare portfolio, the focus on affordability, strategic expansion, and international ventures positions the company as a transformative force in India’s maternal and child healthcare landscape.
